In an open randomized study the effect of the HIV protease inhibitor indinavir in combination with nucleoside analogue reverse transcriptase inhibitors on chronic HIV-related diarrhoea was investigated in 14 late-stage ( CD4 + lymphocyte count < or = 50 x 10 ( 6 ) cells/l ) HIV-infected patients .
